Severe combined immunodeficiency (SCID) is a rare primary immunodeficiency with an overall frequency estimated to be 1 in 75 000 live births. 1 SCID represents a group of diseases characterised by deficient T and B cell function with resulting susceptibility to infection and secondary failure of the patients to thrive. SCID syndromes are caused by multiple genetic defects and are fatal usually within the first year of life. Bone marrow transplantation (BMT) is the only curative treatment available. 2 BMT was introduced in the treatment of primary immunodeficiencies about 30 years ago. Since then BMT has made it possible to cure a substantial number of children who would otherwise not have survived. 2, 3 In Europe, the overall 2-year survival for BMT for SCID is now over 60%. 3 At present, there are only two specialised centres in the United Kingdom for treating children with severe combined immunodeficiency. Both units, Great Ormond Street Hospital for Sick Children and Newcastle General Hospital are each transplanting about 15-20 children per year. Longterm follow-up post BMT of these children shows that the majority (85%) have normal life of good quality, normal growth and development and good overall immune function. 4 Survival however is not without costs as cytotoxic treatment does not discriminate between myeloid and lymphoid cells and other tissues and this in turn may lead to significant incidence of delayed sequelae. 5 Abinun et al 4 did not mention any effects on the developing dentition in their study. There is no long-term data yet available on the dental effects of treatment for SCID.
In this article, we report dental developmental anomalies that have been identified in three children that were successfully transplanted when the programme in Newcastle started in 1987. All three patients received similar conditioning programmes of busulphan (2-4 mg/kg/day, days −9 to −6) and cyclophosphamide (50 mg/kg/day, days −5 to −1) and had T cell-depleted parental haplo-identical bone marrow transplants (T cell depletion in vitro with CAM-PATH 1M and complement).
Case reports

Case 1
This patient underwent BMT at the age of 3 months. At the age of 8 years as part of the follow-up programme, a clinical and radiological dental examination revealed a number of developmental dental anomalies ( Figure 1 ): premature apical (root) closure resulting in short roots of all remaining primary teeth; hypoplasia (poorly formed enamel and dentine) and microdontia (small teeth) of the crowns of erupted permanent molars and incisors; hypoplasia and microdontia of the crowns of unerupted permanent canines; thinning and tapering of the roots of erupted permanent molars and incisors; thinning and tapering of the roots of unerupted permanent teeth canines; failure of development of permanent upper first premolars and lower second premolars.
Case 2
This patient underwent BMT at the age of 2 months. A clinical and radiological dental examination at the age of 7 years revealed a number of dental anomalies (Figure 2 ): hypoplasia and microdontia of the crowns of erupted permanent incisors; hypoplasia and microdontia of the crowns of unerupted permanent upper right incisors; thinning and tapering of the roots of erupted permanent lower incisors. Caries (not necessarily due to SCID as a primary factor) was also present in the deciduous molar teeth.
Case 3
This patient underwent BMT at the age of 1 year. At the age of 12 years, a clinical dental and radiological examination revealed a number of developmental anomalies (Figure 3 ): hypoplasia and microdontia of the crowns of erupted permanent teeth (incisors, canines and molars); thinning and tapering of the roots of erupted permanent molars.
Discussion
The developmental dental anomalies in the case reports can be attributed directly to either (1) the primary conditions (SCID) or (2) its treatment (BMT) with its associated therapeutic regimes. While most of these findings have previously been reported in long-term survivors of childhood cancers who received chemotherapy for a much longer term [6] [7] [8] [9] [10] [11] and in children who received BMT after total body irradiation, 12 no previous findings have been documented in children receiving short-term chemotherapy without irradiation followed by BMT in the management of SCID. Acute toxicity induced by chemotherapy can be related to the proliferation kinetics of individual cell populations. The most susceptible structures are therefore those organs with a high cell turnover rate such as the oral and intestinal mucosa, bone marrow, hair follicle, testes and the liver. In addition to these factors damage to tissues and organs with low repair potential often results in deficits and defects that are prolonged and permanent. This is particularly true of the enamel organ and developing teeth. The primary teeth begin developing at about 6 week's gestation and are not complete until 3-4 years of age. The permanent teeth begin developing just before birth (first permanent molars) and with the exception of the wisdom teeth (third permanent molars) continue until about 15 years of age. Root development continues for 3-4 years after eruption of the crown of a tooth.
Incomplete calcification, enamel hypoplasia, arrested or stunted root development, thinning and tapering of roots, premature closure of root apices, delayed or arrested tooth development, microdontia (small teeth) and failure of tooth development or hypodontia have been reported in children surviving longer courses (6-30 months) of cancer chemotherapy. [6] [7] [8] [9] [10] [11] In our reported cases, even the short course of chemotherapy necessary for myeloablation before bone marrow transplantation in the treatment of severe combined immunodeficiency resulted in the development of the severe dental anomalies shown in Figures 1, 2 and 3 .
These three case reports are not an exhaustive survey of the population of SCID patients treated. The permanent dentition erupts between 6 and 14 years of age (except the wisdom teeth) and so all developmental dental defects cannot be completely examined until time has elapsed after BMT. However it is essential that any SCID work-up protocol and follow-up programme involves specialist input from a paediatric dental service. This would ensure elimination of oral infection pre-BMT and correct preventive and dental developmental advice and treatment post BMT.
